Basic Information
The company mainly develops devices capable of repairing human heart tissue using proprietary technology. This proprietary technology is actually a type of extracellular matrix (ECM) technology, which can address medical issues related to congestive heart failure, heart valves, and cardiovascular diseases in clinical applications.
CorMatrix Cardiovascular
Georgia,United States of America
51~100 people
December 01, 2001
ecm@cormatrix.com

